Corante

About this author
Zack Lynch is author of The Neuro Revolution: How Brain Science Is Changing Our World (St. Martin's Press, July 2009).
He is the founder and executive director of the Neurotechnology Industry Organization (NIO) and co-founder of NeuroInsights. He serves on the advisory boards of the McGovern Institute for Brain Research at MIT, the Center for Neuroeconomic Studies, Science Progress, and SocialText, a social software company. Please send newsworthy items or feedback - to Zack Lynch.
Follow me on Twitter at @neurorev
Receive by email

GUEST AUTHOR ARCHIVES
THE NEURO REVOLUTION
TNRCoverWeb120.jpg Buy on Amazon
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

Brain Waves

« Interpreting the Political Brain | Main | Blade Runner Voted Best Movie Ever »

August 26, 2004

Neuroeconomics 2004 conference

Email This Entry

Posted by Zack Lynch

The intersection of economics and neuroscience offers tantalizing potential for the advancement of both disciplines as well as being a new field of study in its own right: Neuroeconomics (click for previous neuroeconomics posts on Brain Waves)

The Human Neuroimaging Laboratory at The Baylor College of Medicine is sponsoring the 2004 Neuroeconomics conference in Charleston, SC. on September 16-19, 2004.

Update: Turns out that the Montague group is organizing, but not sponsoring the conference ($500 registration fees). Thanks to Stanford's Antonio Rangel for the clarification.

Comments (0) + TrackBacks (0) | Category: Neuroeconomics



EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
Neurotech 2010: Translational Researchers Highlight Innovation
The Neuro Revolution in China Progressing
Speakers for Neurotech 2010 - Boston, May 19-20
Giving the Brain a Voice: NIO Public Policy Tour in DC tomorrow
McGovern Institue for Brain Research at MIT Goes Web 2.0
The Neurodiagnostics Report 2010: Brain Imaging, Biomarkers and NeuroInformatics
Neuropharma FDA Approvals Down in 2009
Tel Aviv Neurotech Cluster Thrives